nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—CXCL8—malignant glioma	0.47	0.555	CbGaD
Tolmetin—PTGS1—malignant glioma	0.24	0.283	CbGaD
Tolmetin—PTGS2—malignant glioma	0.137	0.162	CbGaD
Tolmetin—MPO—endothelium—malignant glioma	0.00252	0.096	CbGeAlD
Tolmetin—MPO—blood vessel—malignant glioma	0.00232	0.0885	CbGeAlD
Tolmetin—TDO2—central nervous system—malignant glioma	0.00199	0.0758	CbGeAlD
Tolmetin—TDO2—brain—malignant glioma	0.00158	0.0602	CbGeAlD
Tolmetin—CXCL8—medulla oblongata—malignant glioma	0.00151	0.0577	CbGeAlD
Tolmetin—CXCL8—midbrain—malignant glioma	0.00138	0.0528	CbGeAlD
Tolmetin—CXCL8—spinal cord—malignant glioma	0.00135	0.0515	CbGeAlD
Tolmetin—PTGS1—endothelium—malignant glioma	0.00119	0.0455	CbGeAlD
Tolmetin—PTGS2—endothelium—malignant glioma	0.00114	0.0435	CbGeAlD
Tolmetin—PTGS1—blood vessel—malignant glioma	0.0011	0.042	CbGeAlD
Tolmetin—CXCL8—cerebellum—malignant glioma	0.00107	0.0408	CbGeAlD
Tolmetin—PTGS2—blood vessel—malignant glioma	0.00105	0.0401	CbGeAlD
Tolmetin—CXCL8—brain—malignant glioma	0.000869	0.0331	CbGeAlD
Tolmetin—MPO—spinal cord—malignant glioma	0.000789	0.0301	CbGeAlD
Tolmetin—Zolpidem—PTGS1—malignant glioma	0.000761	0.113	CrCbGaD
Tolmetin—Ketorolac—PTGS1—malignant glioma	0.000707	0.105	CrCbGaD
Tolmetin—SLC22A6—brain—malignant glioma	0.000678	0.0259	CbGeAlD
Tolmetin—Bromfenac—PTGS1—malignant glioma	0.000678	0.101	CrCbGaD
Tolmetin—MPO—central nervous system—malignant glioma	0.00064	0.0244	CbGeAlD
Tolmetin—PTGS2—embryo—malignant glioma	0.000628	0.0239	CbGeAlD
Tolmetin—Lumiracoxib—PTGS1—malignant glioma	0.000577	0.0859	CrCbGaD
Tolmetin—Indomethacin—CXCL8—malignant glioma	0.000545	0.0811	CrCbGaD
Tolmetin—PTGS1—telencephalon—malignant glioma	0.000534	0.0204	CbGeAlD
Tolmetin—Fenbufen—PTGS1—malignant glioma	0.000525	0.0781	CrCbGaD
Tolmetin—PTGS2—telencephalon—malignant glioma	0.000511	0.0195	CbGeAlD
Tolmetin—MPO—brain—malignant glioma	0.000508	0.0194	CbGeAlD
Tolmetin—Suprofen—PTGS1—malignant glioma	0.000437	0.0651	CrCbGaD
Tolmetin—Ketorolac—PTGS2—malignant glioma	0.000404	0.0602	CrCbGaD
Tolmetin—PTGS2—medulla oblongata—malignant glioma	0.000401	0.0153	CbGeAlD
Tolmetin—Bromfenac—PTGS2—malignant glioma	0.000388	0.0577	CrCbGaD
Tolmetin—Indomethacin—PPARG—malignant glioma	0.000376	0.056	CrCbGaD
Tolmetin—PTGS1—spinal cord—malignant glioma	0.000374	0.0143	CbGeAlD
Tolmetin—PTGS2—midbrain—malignant glioma	0.000367	0.014	CbGeAlD
Tolmetin—PTGS2—spinal cord—malignant glioma	0.000358	0.0136	CbGeAlD
Tolmetin—Lumiracoxib—PTGS2—malignant glioma	0.00033	0.0491	CrCbGaD
Tolmetin—PTGS1—central nervous system—malignant glioma	0.000304	0.0116	CbGeAlD
Tolmetin—Fenbufen—PTGS2—malignant glioma	0.0003	0.0447	CrCbGaD
Tolmetin—PTGS2—central nervous system—malignant glioma	0.00029	0.0111	CbGeAlD
Tolmetin—PTGS2—cerebellum—malignant glioma	0.000284	0.0108	CbGeAlD
Tolmetin—Indomethacin—PTGS1—malignant glioma	0.000278	0.0414	CrCbGaD
Tolmetin—Suprofen—PTGS2—malignant glioma	0.00025	0.0372	CrCbGaD
Tolmetin—PTGS1—brain—malignant glioma	0.000241	0.00919	CbGeAlD
Tolmetin—PTGS2—brain—malignant glioma	0.00023	0.00879	CbGeAlD
Tolmetin—Indomethacin—PTGS2—malignant glioma	0.000159	0.0237	CrCbGaD
Tolmetin—Vascular purpura—Temozolomide—malignant glioma	9.67e-05	0.0438	CcSEcCtD
Tolmetin—Purpura—Temozolomide—malignant glioma	8.98e-05	0.0406	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Carmustine—malignant glioma	8.95e-05	0.0405	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Temozolomide—malignant glioma	7.79e-05	0.0353	CcSEcCtD
Tolmetin—Dysuria—Temozolomide—malignant glioma	6.99e-05	0.0316	CcSEcCtD
Tolmetin—Weight increased—Temozolomide—malignant glioma	6.81e-05	0.0308	CcSEcCtD
Tolmetin—Renal failure—Carmustine—malignant glioma	6.78e-05	0.0307	CcSEcCtD
Tolmetin—Weight decreased—Temozolomide—malignant glioma	6.77e-05	0.0306	CcSEcCtD
Tolmetin—Stomatitis—Carmustine—malignant glioma	6.73e-05	0.0304	CcSEcCtD
Tolmetin—Urinary tract infection—Carmustine—malignant glioma	6.71e-05	0.0303	CcSEcCtD
Tolmetin—Stomatitis—Temozolomide—malignant glioma	6.5e-05	0.0294	CcSEcCtD
Tolmetin—Urinary tract infection—Temozolomide—malignant glioma	6.48e-05	0.0293	CcSEcCtD
Tolmetin—Hepatitis—Temozolomide—malignant glioma	5.99e-05	0.0271	CcSEcCtD
Tolmetin—Visual impairment—Carmustine—malignant glioma	5.97e-05	0.027	CcSEcCtD
Tolmetin—PTGS1—Selenium Micronutrient Network—TNF—malignant glioma	5.82e-05	0.000495	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—CAV1—malignant glioma	5.8e-05	0.000494	CbGpPWpGaD
Tolmetin—Visual impairment—Temozolomide—malignant glioma	5.77e-05	0.0261	CcSEcCtD
Tolmetin—CXCL8—GPCR downstream signaling—BDKRB2—malignant glioma	5.7e-05	0.000485	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CXCR3—malignant glioma	5.66e-05	0.000482	CbGpPWpGaD
Tolmetin—Erythema multiforme—Temozolomide—malignant glioma	5.66e-05	0.0256	CcSEcCtD
Tolmetin—PTGS1—Metabolism—COX8A—malignant glioma	5.65e-05	0.000481	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IFNG—malignant glioma	5.64e-05	0.00048	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	5.59e-05	0.000476	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	5.58e-05	0.000475	CbGpPWpGaD
Tolmetin—Tinnitus—Temozolomide—malignant glioma	5.58e-05	0.0253	CcSEcCtD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—SLC5A5—malignant glioma	5.45e-05	0.000464	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—AKT1—malignant glioma	5.45e-05	0.000464	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	5.4e-05	0.00046	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PIK3CG—malignant glioma	5.28e-05	0.00045	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CXCL8—malignant glioma	5.25e-05	0.000447	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—SLC6A3—malignant glioma	5.19e-05	0.000442	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—KNG1—malignant glioma	5.19e-05	0.000442	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—BDKRB2—malignant glioma	5.18e-05	0.000441	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—MYC—malignant glioma	5.15e-05	0.000438	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—VEGFA—malignant glioma	5.11e-05	0.000435	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—TP53—malignant glioma	5.11e-05	0.000435	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PPARG—malignant glioma	5.1e-05	0.000434	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—STAT3—malignant glioma	5.06e-05	0.000431	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL1B—malignant glioma	5.03e-05	0.000429	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CASP3—malignant glioma	5.02e-05	0.000428	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL2—malignant glioma	5.02e-05	0.000427	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	5.01e-05	0.000426	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SUFU—malignant glioma	4.92e-05	0.000419	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HEY2—malignant glioma	4.86e-05	0.000414	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	4.85e-05	0.000413	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ASMT—malignant glioma	4.81e-05	0.000409	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	4.79e-05	0.000408	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—KRAS—malignant glioma	4.76e-05	0.000405	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MMP9—malignant glioma	4.75e-05	0.000404	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GFAP—malignant glioma	4.75e-05	0.000404	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—KNG1—malignant glioma	4.71e-05	0.000401	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.7e-05	0.0004	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PIK3CD—malignant glioma	4.64e-05	0.000395	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—TNF—malignant glioma	4.62e-05	0.000393	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SPHK1—malignant glioma	4.59e-05	0.000391	CbGpPWpGaD
Tolmetin—Chest pain—Carmustine—malignant glioma	4.59e-05	0.0208	CcSEcCtD
Tolmetin—PTGS1—Metabolism—BCAN—malignant glioma	4.52e-05	0.000385	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCR4—malignant glioma	4.5e-05	0.000383	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HEY1—malignant glioma	4.5e-05	0.000383	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—COX8A—malignant glioma	4.49e-05	0.000382	CbGpPWpGaD
Tolmetin—Oedema—Carmustine—malignant glioma	4.4e-05	0.0199	CcSEcCtD
Tolmetin—CXCL8—Signaling Pathways—HIST1H3B—malignant glioma	4.37e-05	0.000372	CbGpPWpGaD
Tolmetin—Thrombocytopenia—Carmustine—malignant glioma	4.31e-05	0.0195	CcSEcCtD
Tolmetin—PTGS2—Disease—BCAN—malignant glioma	4.28e-05	0.000365	CbGpPWpGaD
Tolmetin—Anaphylactic shock—Temozolomide—malignant glioma	4.25e-05	0.0192	CcSEcCtD
Tolmetin—Oedema—Temozolomide—malignant glioma	4.25e-05	0.0192	CcSEcCtD
Tolmetin—CXCL8—Signaling by GPCR—MMP3—malignant glioma	4.17e-05	0.000355	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—F2—malignant glioma	4.17e-05	0.000355	CbGpPWpGaD
Tolmetin—Thrombocytopenia—Temozolomide—malignant glioma	4.16e-05	0.0188	CcSEcCtD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	4.08e-05	0.000347	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PIK3CB—malignant glioma	4.05e-05	0.000345	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PTGS2—malignant glioma	4.01e-05	0.000341	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	4.01e-05	0.000341	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—JAG2—malignant glioma	3.99e-05	0.00034	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MYC—malignant glioma	3.92e-05	0.000334	CbGpPWpGaD
Tolmetin—Somnolence—Carmustine—malignant glioma	3.91e-05	0.0177	CcSEcCtD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	3.88e-05	0.00033	CbGpPWpGaD
Tolmetin—PTGS2—Disease—DTX1—malignant glioma	3.87e-05	0.00033	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—TP53—malignant glioma	3.86e-05	0.000329	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—EGFR—malignant glioma	3.84e-05	0.000327	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	3.82e-05	0.000325	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ASMT—malignant glioma	3.82e-05	0.000325	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	3.81e-05	0.000324	CbGpPWpGaD
Tolmetin—Somnolence—Temozolomide—malignant glioma	3.78e-05	0.0171	CcSEcCtD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	3.76e-05	0.00032	CbGpPWpGaD
Tolmetin—Constipation—Carmustine—malignant glioma	3.76e-05	0.017	CcSEcCtD
Tolmetin—Dyspepsia—Temozolomide—malignant glioma	3.74e-05	0.0169	CcSEcCtD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.73e-05	0.000317	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TNF—malignant glioma	3.65e-05	0.000311	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—IDH2—malignant glioma	3.64e-05	0.00031	CbGpPWpGaD
Tolmetin—Constipation—Temozolomide—malignant glioma	3.64e-05	0.0165	CcSEcCtD
Tolmetin—Gastrointestinal pain—Carmustine—malignant glioma	3.6e-05	0.0163	CcSEcCtD
Tolmetin—PTGS2—Metabolism—BCAN—malignant glioma	3.59e-05	0.000305	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—MMP2—malignant glioma	3.54e-05	0.000301	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PTEN—malignant glioma	3.5e-05	0.000298	CbGpPWpGaD
Tolmetin—Abdominal pain—Carmustine—malignant glioma	3.48e-05	0.0157	CcSEcCtD
Tolmetin—Body temperature increased—Carmustine—malignant glioma	3.48e-05	0.0157	CcSEcCtD
Tolmetin—Gastrointestinal pain—Temozolomide—malignant glioma	3.48e-05	0.0157	CcSEcCtD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.43e-05	0.000292	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP2B6—malignant glioma	3.42e-05	0.000292	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	3.42e-05	0.000291	CbGpPWpGaD
Tolmetin—Urticaria—Temozolomide—malignant glioma	3.38e-05	0.0153	CcSEcCtD
Tolmetin—CXCL8—Signaling Pathways—H3F3A—malignant glioma	3.38e-05	0.000287	CbGpPWpGaD
Tolmetin—Abdominal pain—Temozolomide—malignant glioma	3.36e-05	0.0152	CcSEcCtD
Tolmetin—Body temperature increased—Temozolomide—malignant glioma	3.36e-05	0.0152	CcSEcCtD
Tolmetin—CXCL8—GPCR downstream signaling—F2—malignant glioma	3.35e-05	0.000285	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CXCR3—malignant glioma	3.34e-05	0.000285	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—YWHAE—malignant glioma	3.25e-05	0.000277	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NTRK2—malignant glioma	3.25e-05	0.000277	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FLT1—malignant glioma	3.24e-05	0.000276	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—DUSP6—malignant glioma	3.22e-05	0.000274	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TP53—malignant glioma	3.22e-05	0.000274	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	3.21e-05	0.000273	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CG—malignant glioma	3.21e-05	0.000273	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—JAG1—malignant glioma	3.18e-05	0.000271	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NOTCH3—malignant glioma	3.17e-05	0.00027	CbGpPWpGaD
Tolmetin—Asthenia—Carmustine—malignant glioma	3.16e-05	0.0143	CcSEcCtD
Tolmetin—PTGS1—Metabolism—IDH1—malignant glioma	3.13e-05	0.000267	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FBXW7—malignant glioma	3.12e-05	0.000265	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—BDKRB2—malignant glioma	3.06e-05	0.00026	CbGpPWpGaD
Tolmetin—Asthenia—Temozolomide—malignant glioma	3.05e-05	0.0138	CcSEcCtD
Tolmetin—CXCL8—Signaling by GPCR—F2—malignant glioma	3.04e-05	0.000259	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HEY2—malignant glioma	3.04e-05	0.000259	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SPHK1—malignant glioma	3.03e-05	0.000258	CbGpPWpGaD
Tolmetin—Diarrhoea—Carmustine—malignant glioma	3.01e-05	0.0136	CcSEcCtD
Tolmetin—PTGS1—Metabolism—CYP2C18—malignant glioma	2.97e-05	0.000253	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IDH1—malignant glioma	2.97e-05	0.000253	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—AKT2—malignant glioma	2.94e-05	0.00025	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CG—malignant glioma	2.91e-05	0.000248	CbGpPWpGaD
Tolmetin—Dizziness—Carmustine—malignant glioma	2.91e-05	0.0132	CcSEcCtD
Tolmetin—Diarrhoea—Temozolomide—malignant glioma	2.91e-05	0.0132	CcSEcCtD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	2.9e-05	0.000247	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—IDH2—malignant glioma	2.89e-05	0.000246	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PTPN11—malignant glioma	2.86e-05	0.000244	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NOTCH2—malignant glioma	2.84e-05	0.000242	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CD—malignant glioma	2.82e-05	0.00024	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HEY1—malignant glioma	2.81e-05	0.00024	CbGpPWpGaD
Tolmetin—Dizziness—Temozolomide—malignant glioma	2.81e-05	0.0127	CcSEcCtD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.8e-05	0.000238	CbGpPWpGaD
Tolmetin—Vomiting—Carmustine—malignant glioma	2.8e-05	0.0127	CcSEcCtD
Tolmetin—CXCL8—Signaling Pathways—KNG1—malignant glioma	2.78e-05	0.000237	CbGpPWpGaD
Tolmetin—Headache—Carmustine—malignant glioma	2.76e-05	0.0125	CcSEcCtD
Tolmetin—PTGS2—Disease—HIST1H3B—malignant glioma	2.73e-05	0.000233	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.73e-05	0.000232	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP2B6—malignant glioma	2.72e-05	0.000231	CbGpPWpGaD
Tolmetin—Vomiting—Temozolomide—malignant glioma	2.7e-05	0.0122	CcSEcCtD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	2.67e-05	0.000227	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—AKT2—malignant glioma	2.67e-05	0.000227	CbGpPWpGaD
Tolmetin—Headache—Temozolomide—malignant glioma	2.66e-05	0.0121	CcSEcCtD
Tolmetin—CXCL8—Signaling Pathways—NTRK1—malignant glioma	2.65e-05	0.000226	CbGpPWpGaD
Tolmetin—Nausea—Carmustine—malignant glioma	2.61e-05	0.0118	CcSEcCtD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	2.61e-05	0.000222	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CD—malignant glioma	2.56e-05	0.000218	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.55e-05	0.000217	CbGpPWpGaD
Tolmetin—Nausea—Temozolomide—malignant glioma	2.53e-05	0.0114	CcSEcCtD
Tolmetin—PTGS2—Disease—JAG2—malignant glioma	2.5e-05	0.000212	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—IDH1—malignant glioma	2.49e-05	0.000212	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	2.49e-05	0.000212	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PIK3CA—malignant glioma	2.47e-05	0.00021	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MMP3—malignant glioma	2.47e-05	0.00021	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	2.47e-05	0.00021	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.46e-05	0.00021	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CB—malignant glioma	2.46e-05	0.000209	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CDKN2B—malignant glioma	2.44e-05	0.000208	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SPHK1—malignant glioma	2.41e-05	0.000205	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTT1—malignant glioma	2.4e-05	0.000204	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PTK2—malignant glioma	2.37e-05	0.000202	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP2C18—malignant glioma	2.36e-05	0.000201	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—RAF1—malignant glioma	2.35e-05	0.0002	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HES1—malignant glioma	2.33e-05	0.000198	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NCOR1—malignant glioma	2.32e-05	0.000197	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—RAF1—malignant glioma	2.29e-05	0.000195	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.26e-05	0.000193	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—IL2—malignant glioma	2.26e-05	0.000192	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.24e-05	0.000191	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CB—malignant glioma	2.23e-05	0.00019	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.22e-05	0.000189	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PDGFRA—malignant glioma	2.22e-05	0.000189	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.19e-05	0.000187	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SPP1—malignant glioma	2.15e-05	0.000183	CbGpPWpGaD
Tolmetin—PTGS2—Disease—H3F3A—malignant glioma	2.11e-05	0.00018	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—BCHE—malignant glioma	2.09e-05	0.000178	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SLC5A5—malignant glioma	2.07e-05	0.000176	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL2—malignant glioma	2.05e-05	0.000175	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TERT—malignant glioma	2.04e-05	0.000174	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.02e-05	0.000172	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—AKT1—malignant glioma	2.02e-05	0.000172	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PDGFB—malignant glioma	1.99e-05	0.00017	CbGpPWpGaD
Tolmetin—PTGS2—Disease—JAG1—malignant glioma	1.99e-05	0.00017	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FGFR1—malignant glioma	1.98e-05	0.000169	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.95e-05	0.000166	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.95e-05	0.000166	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HIF1A—malignant glioma	1.95e-05	0.000166	CbGpPWpGaD
Tolmetin—PTGS2—Disease—FBXW7—malignant glioma	1.95e-05	0.000166	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.94e-05	0.000165	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTT1—malignant glioma	1.91e-05	0.000162	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CAV1—malignant glioma	1.89e-05	0.000161	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—KDR—malignant glioma	1.87e-05	0.000159	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.85e-05	0.000157	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—F2—malignant glioma	1.8e-05	0.000153	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FN1—malignant glioma	1.8e-05	0.000153	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PTGS1—malignant glioma	1.79e-05	0.000152	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.78e-05	0.000152	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—BAD—malignant glioma	1.78e-05	0.000151	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NOTCH1—malignant glioma	1.76e-05	0.00015	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CD80—malignant glioma	1.72e-05	0.000147	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CG—malignant glioma	1.72e-05	0.000147	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—APC—malignant glioma	1.72e-05	0.000147	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EGF—malignant glioma	1.7e-05	0.000145	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PTPN11—malignant glioma	1.69e-05	0.000144	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.69e-05	0.000144	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTP1—malignant glioma	1.66e-05	0.000142	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—BCHE—malignant glioma	1.66e-05	0.000141	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SLC5A5—malignant glioma	1.64e-05	0.00014	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CAT—malignant glioma	1.62e-05	0.000138	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—BRAF—malignant glioma	1.62e-05	0.000138	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AKT2—malignant glioma	1.57e-05	0.000134	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—EGFR—malignant glioma	1.57e-05	0.000133	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.55e-05	0.000132	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—NCOR1—malignant glioma	1.53e-05	0.00013	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CDKN2B—malignant glioma	1.53e-05	0.00013	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CD—malignant glioma	1.51e-05	0.000129	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CA—malignant glioma	1.5e-05	0.000128	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—KRAS—malignant glioma	1.48e-05	0.000126	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HES1—malignant glioma	1.46e-05	0.000124	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NCOR1—malignant glioma	1.45e-05	0.000123	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FGF2—malignant glioma	1.45e-05	0.000123	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PDGFRA—malignant glioma	1.39e-05	0.000118	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CA—malignant glioma	1.36e-05	0.000116	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MDM2—malignant glioma	1.36e-05	0.000115	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RAF1—malignant glioma	1.35e-05	0.000115	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.34e-05	0.000114	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ERBB2—malignant glioma	1.34e-05	0.000114	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTP1—malignant glioma	1.32e-05	0.000112	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CB—malignant glioma	1.32e-05	0.000112	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CAT—malignant glioma	1.29e-05	0.000109	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TERT—malignant glioma	1.28e-05	0.000109	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HLA-A—malignant glioma	1.28e-05	0.000109	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PDGFB—malignant glioma	1.25e-05	0.000106	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CAV1—malignant glioma	1.25e-05	0.000106	CbGpPWpGaD
Tolmetin—PTGS2—Disease—FGFR1—malignant glioma	1.24e-05	0.000106	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—AKT1—malignant glioma	1.22e-05	0.000104	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HIF1A—malignant glioma	1.22e-05	0.000104	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NCOR1—malignant glioma	1.21e-05	0.000103	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CASP3—malignant glioma	1.21e-05	0.000103	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL2—malignant glioma	1.21e-05	0.000103	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.19e-05	0.000101	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CAV1—malignant glioma	1.18e-05	0.000101	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MMP9—malignant glioma	1.15e-05	9.76e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PTEN—malignant glioma	1.14e-05	9.7e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CG—malignant glioma	1.14e-05	9.67e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—AKT1—malignant glioma	1.11e-05	9.46e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—BAD—malignant glioma	1.11e-05	9.46e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NOTCH1—malignant glioma	1.1e-05	9.37e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PPARG—malignant glioma	1.1e-05	9.33e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CD80—malignant glioma	1.08e-05	9.18e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—APC—malignant glioma	1.08e-05	9.16e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—EGF—malignant glioma	1.06e-05	9.06e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PTPN11—malignant glioma	1.06e-05	9e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—VEGFA—malignant glioma	1.03e-05	8.76e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—STAT3—malignant glioma	1.02e-05	8.68e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—BRAF—malignant glioma	1.01e-05	8.61e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CD—malignant glioma	9.99e-06	8.5e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CAV1—malignant glioma	9.9e-06	8.43e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—AKT2—malignant glioma	9.85e-06	8.39e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MYC—malignant glioma	9.47e-06	8.06e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PIK3CD—malignant glioma	9.46e-06	8.06e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9.46e-06	8.05e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EGFR—malignant glioma	9.26e-06	7.89e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—FGF2—malignant glioma	9.06e-06	7.71e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CG—malignant glioma	9.02e-06	7.68e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—KRAS—malignant glioma	8.75e-06	7.45e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CB—malignant glioma	8.7e-06	7.41e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PPARG—malignant glioma	8.7e-06	7.41e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PTGS2—malignant glioma	8.62e-06	7.34e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MDM2—malignant glioma	8.48e-06	7.22e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RAF1—malignant glioma	8.45e-06	7.19e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ERBB2—malignant glioma	8.36e-06	7.12e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PIK3CB—malignant glioma	8.25e-06	7.02e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CA—malignant glioma	8.04e-06	6.84e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CD—malignant glioma	7.93e-06	6.75e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TP53—malignant glioma	7.78e-06	6.62e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PTEN—malignant glioma	7.52e-06	6.4e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PTEN—malignant glioma	7.13e-06	6.07e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CB—malignant glioma	6.91e-06	5.88e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AKT1—malignant glioma	6.57e-06	5.59e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—STAT3—malignant glioma	6.38e-06	5.43e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PTEN—malignant glioma	5.97e-06	5.08e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MYC—malignant glioma	5.92e-06	5.04e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—EGFR—malignant glioma	5.79e-06	4.93e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—KRAS—malignant glioma	5.47e-06	4.66e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CA—malignant glioma	5.31e-06	4.52e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PIK3CA—malignant glioma	5.03e-06	4.28e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—AKT1—malignant glioma	4.33e-06	3.69e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CA—malignant glioma	4.21e-06	3.59e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—AKT1—malignant glioma	4.11e-06	3.5e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—AKT1—malignant glioma	3.44e-06	2.93e-05	CbGpPWpGaD
